Company Overview of Hydra Biosciences, Inc.
Hydra Biosciences, Inc. develops therapeutic agents that treat pain, inflammation, anxiety, renal, and pulmonary diseases. The company was founded in 2001 and is based in Cambridge, Massachusetts.
45 Moulton Street
Cambridge, MA 02138
Founded in 2001
Key Executives for Hydra Biosciences, Inc.
Chief Executive Officer, President and Director
Scientific Co-Founder and Member of Scientific Advisory Board - Cardiac Regeneration
Scientific Co-Founder and Member of Scientific Avisory Board - Cardiac Regeneration
Scientific Co-Founder, Chair of Scientific Advisory Board and Member of Pain Medical Advisory Board
Interim Chief Financial Officer
Compensation as of Fiscal Year 2015.
Hydra Biosciences, Inc. Key Developments
Hydra Biosciences, Inc. Presents at Boston Biotech East West CEO Conference, Jan-09-2016 09:55 AM
Jan 1 16
Hydra Biosciences, Inc. Presents at Boston Biotech East West CEO Conference, Jan-09-2016 09:55 AM. Venue: Four Seasons Hotel, 757 Market St., San Francisco, CA 94103, United States. Speakers: Russell H. Herndon, Chief Executive Officer, President and Director.
Hydra Biosciences, Inc. Presents at 8th Annual Biotech Showcase Investor Conference 2016, Jan-11-2016 03:15 PM
Dec 8 15
Hydra Biosciences, Inc. Presents at 8th Annual Biotech Showcase Investor Conference 2016, Jan-11-2016 03:15 PM. Venue: Parc 55 San Francisco, 55 Cyril Magnin Street, San Francisco, CA 94102, United States. Speakers: Russell H. Herndon, Chief Executive Officer, President and Director.
Hydra Biosciences Announces the Formation of a Pulmonary Medical Advisory Board
Aug 5 15
Hydra Biosciences announced the formation of a Pulmonary Medical Advisory Board. Three experts in pulmonary medicine, Dr. William Busse, Dr. Paul O’Byrne and Dr. Sven-Erik Dahlén, were appointed to the board. The three members of the advisory board are leaders in allergy and immunology, asthma and pulmonology: William W. Busse, M.D., is professor of Medicine at the University of Wisconsin Medical School, where he has taught since 1974 and has served as head of the Allergy and Clinical Immunology Division and Chair of Medicine. Paul O’Byrne, M.D., is the E. J. Moran Campbell Professor of Medicine and Chair of the Department of Medicine at the Michael G. DeGroote School of Medicine at McMaster University. He is also the executive director of the Firestone Institute for Respiratory Health at St. Joseph’s Healthcare. Sven-Erik Dahlén, M.D., Ph.D., is a professor of experimental asthma and allergy research and the director of the Centre for Allergy Research at Karolinska Institutet in Stockholm. He has held many positions and appointments in pulmonary medicine, including serving as the Scientific Advisor for the Swedish Public Health Institute and on multiple boards at the Karolinska Institutet.
Similar Private Companies By Industry
Recent Private Companies Transactions
March 17, 2015